In this context, we would like to clarify once again that disease recurrence refers to both recurrent PAs, which lead to pathological GH and IGF-I levels indicative of persistent acromegaly, and residual PAs that could not be completely resected and therefore require further treatment, such as postoperative medical therapy or radiotherapy. Here, GH1 is linked to acromegaly.